Pharmafile Logo
- PMLiVE

Pharmaceutical Market Europe – December 2024

Sanofi’s John Forni on the escalating challenges of treating COPD; The need for a human touch in an AI world; PMGroup celebrates the 24th PMEAs!

- PMLiVE

Pharmaceutical Market Europe – November 2024

The explosive growth of Gen AI; Liberating patient pathways; Closing health equity gaps

- PMLiVE

Pharmaceutical Market Europe – October 2024

Boehringer Ingelheim’s Ulrike Graefe-Mody on her career path; Driving launch excellence; Top trends coming out of ESMO 2024

- PMLiVE

Pharmaceutical Market Europe – September 2024

The challenges of environmental sustainability; ‘Causes That Count, Health’ report; Rethinking neurodegeneration

- PMLiVE

Pharmaceutical Market Europe – July/August 2024

Merck’s Doina Ionescu on her professional journey; Full coverage of Communiqué 2024; Omnichannel opportunities

- PMLiVE

Pharmaceutical Market Europe – June 2024

GSK’s Jack Harris on innovation in oncology; Harnessing creativity in a digital age; Sustainability in pharma

- PMLiVE

Pharmaceutical Market Europe – May 2024

Interview with Ipsen’s Ioana Parsons on her new role; Celebrating comms excellence; Getting trial diversity right

- PMLiVE

Pharmaceutical Market Europe – April 2024

Astellas' Marci English on managing the menopause; Clinigen’s Lorna Pender on treating rare diseases; the science behind behaviour change

- PMLiVE

Pharmaceutical Market Europe – March 2024

Interview with Sanofi’s Rippon Ubhi on her new role; Optimising MS care and patient outcomes; Overcoming pharma web strategy challenges

PME Feb 2024

Pharmaceutical Market Europe – February 2024

Diversity, equity and inclusion in medical research; Marking International Day of Women and Girls in Science; Incentivising innovation in antibiotics

- PMLiVE

Pharmaceutical Market Europe – January 2024

Interview with AstraZeneca’s Ed Piper on patient outcomes; Pharma trends and predictions for 2024; Precision medicine in chronic diseases

- PMLiVE

Pharmaceutical Market Europe – December 2023

Full coverage of the 23rd annual PMEAs; Virtual patient care – a glimpses of an exciting future; Rare diseases – the importance of screening for SMA